Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Resolutions at the Annual General Meeting in Medivir on 3 May 2017

Election of the board of directors and auditorThe annual general meeting in Medivir Aktiebolag (publ) on 3 May 2017 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be six with no deputy board members. Anders Ekblom, Anders R Hallberg, Helena Levander and Anna Malm Bernsten were re-elected as board members and Bengt Julander and Bengt Westermark was elected as a new board members. Anna Malm Bernsten was re-elected as chairman of the board. Öhrlings PricewaterhouseCoopers AB was re-elected as auditor. Remuneration to the board of

TePe acquires U.S. distributor

TePe Munhygienprodukter AB continues its global expansion by integrating U.S. distributor TePe Oral Health Care Inc. in the TePe group as a subsidiary as of 1 July 2017. The subsidiary will operate from its current offices in the Los Angeles area with existing employees and be managed on site by Stefan Vincze, currently Export Manager at TePe. - It is with great optimism that we take this next step in TePe’s development and look forward to the future in the American market with confidence, says Joel Eklund, CEO, TePe Munhygienprodukter AB. The TePe group has grown significantly in

Outokumpu – Manager transaction: Saila Miettinen-Lähde

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Saila Miettinen-Lähde, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing

Outokumpu – Manager transaction: Heikki Malinen

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Heikki Malinen, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing Outokumpu’

Outokumpu – Manager transaction: Kati ter Horst

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET   Outokumpu has received a notification from Kati ter Horst, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing

Outokumpu – Manager transaction: Eeva Sipilä

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Eeva Sipilä, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing Outokumpu’s

Outokumpu – Manager transaction: Markus Akermann

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Markus Akermann, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing

Outokumpu – Manager transaction: Roberto Gualdoni

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm   Outokumpu has received a notification from Roberto Gualdoni, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing Outokumpu’

Outokumpu – Manager transaction: Jorma Ollila

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Jorma Ollila, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing Outokumpu’s

Outokumpu – Manager transaction: Olli Vaartimo

Outokumpu OyjStock exchange releaseMay 3, 2017 at 5.30 pm EET  Outokumpu has received a notification from Olli Vaartimo, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Outokumpu’s Annual General Meeting decided in March 2017 that the annual remuneration of the members of the Board of Directors will be paid under the condition that the members of the Board of Directors use 40% of the annual remuneration for purchasing Outokumpu’

Rejlers contributes to qualified work opportunities for the newly arrived

Tillväxtverket, the Swedish Agency for Economic and Regional Growth, has granted financial support for a feasability study towards creating employment within the Railway industry for newly arrived individuals through education. The assignment is being carried out by Rejlers AB in cooperation with Nässjö Näringsliv AB / Nordic Infracenter.The study aims at analyzing and creating new comprehensible models for employability and employment matching based on employer demands and needs. These models will play a vital role in finding the most suited individuals for future employment after having

Advantech Launches AIMB-242 Mini-ITX Featuring High Computing and Graphic Performance

Built with new Xeon and 6th generation Intel® Core™ mobile processorsApril 25, 2017, Munich –Advantech, a leading embedded computing solution provider, today announced the release of its new high-end industrial Mini-ITX motherboard line. AIMB-242  is based on the Intel® QM170/CM236 chipset and the latest 6th generation Intel® Core™ I & Xeon E3 processors, supporting non-ECC & ECC memory capacities (only for WG2 sku) up to 32GB. AIMB-242 uses DDR4 2133MHz memory and comes

T2 New issue

SpareBank 1 SR-Bank has today issued an 11NC6 NOK 500 million T2 bond. The coupon is set at 3 months Nibor + 1.52 per cent. Issue date is 9 May 2017 and the bond will be applied for listing on Oslo Børs. The loan limit under the loan agreement is NOK 1 000 million.   SpareBank 1 SR-Bank has bought back NOK 59 million in T2 NO0010664568/ SRBANK07 at Nibor + 0.80 per cent with settlement date 9 May 2017, equivalent to a price of 101,147. Outstanding volume other than own account in the market is now NOK 766 million.  Nordea Markets, SR-Bank Markets and Swedbank Norway acted as managers.

#17-404 Listing of Double knock out binary warrants issued by SG Issuer

As from May 04, 2017, 2 Double knock out binary warrants issued by SG Issuer will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: SG Issuer Type of security: Call Double knock out binary warrants of European type Execution: Automatic cash settlement Term: As from May 04, 2017 to expiry date Market Maker: Societe Generale Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing

Veidekke ASA: PRESENTATION OF FIRST QUARTER RESULTS 2017

Please note that Veidekke will hold its presentation of its results for the first quarter 2017 on Thursday, 11 May at 8.00 a.m. at Hotel Continental, Teatersalen 2 - Stortingsgaten 24/26, Oslo. The presentation and the following Q&A session, can be followed via webcast at http://veidekke.com/en. It will be possible to ask questions through web. To attend the presentation on Thursday, 11 May, please send an email to anita.pettersen@veidekke.no or register to Anita Pettersen, phone +47 996 45 414.

New positive study results on diabetic nephropathy with Vicore Pharma's candidate drug C21

C21 combined with an angiotensin receptor blocker (ARB) provides improved treatment effect in type 2 diabetes animal model. Vicore Pharma AB (ticker: VICO), a Swedish biotech company developing drugs that act through the AT2 receptor in the renin angiotensin system, today announced positive results from a preclinical study in which researchers in India have studied the effects of C21 in combination with an ARB on mechanisms of diabetic nephropathy in a type 2 diabetes animal model.The results were published on May 1, 2017 in the scientific journal Biochemical and Biophysical Research

Correction to Stock Exchange Release 3.5.2017 2:00 pm QT GROUP PLC - Managers' Transactions

Stock Exchange Release May 3, 2017 4:00 pm____________________________________________ Person subject to the notification requirement Name: INGMAN DEVELOPMENT OY AB Position: Closely associated person (X) Legal person (1): Closely associated person Name: Ingman, Robert Position: Member of the Board Issuer: QT GROUP OYJ LEI: 743700GO2XU2ZYYDKW67 Notification type: AMENDMENT Reference number: 743700GO2XU2ZYYDKW67_20170503141135_6 Amendment comment: Addition to Managers’ Transactions stock exchange release 3.5.2017 at 2 pm for Ingman Development Oy Ab,

Vestas - Share-based incentive programme 2017

The Board of Directors of Vestas Wind Systems A/S has decided to continue the share-based incentive programme for all participants, including the Executive Management, and launch a new programme for 2017 based on the terms and conditions governing the restricted performance share programme for the year 2016, cf. Vestas’ remuneration policy and general guidelines for incentive pay. The share-based incentive programme follows the structures of the previous programme and will still be based on restricted performance shares. The programme has a performance period of three years and a

#17-201 Listing of Turbo warrants issued by Commerzbank AG

As from May 04, 2017, 3 Turbo warrants issued by Commerzbank AG will be listed on NDX Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Commerzbank AG Type of security: Call and put Turbo warrants of European type Execution: Automatic cash settlement Term: As from May 04, 2017 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@

NRC GROUP ASA: Annual General Meeting held

The Annual General Meeting of NRC Group ASA was held on 3 May 2017. All resolution proposals included in the notice of general meeting were adopted, including the proposal to pay dividend of NOK 0.80 per share. Dividend payments will be made on 19 May 2017 to shareholders as of 3 May 2017, registered as shareholders on 5 May 2017.Attached are the signed minutes of general meeting. For further information, please contact:CFO Dag Fladby, telephone: +47 90 89 19 35.This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading

#17-403 Listing of Mini futures issued by BNP Paribas Arbitrage Issuance B.V.

As from May 04, 2017, 5 Mini futures issued by BNP Paribas Arbitrage Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Arbitrage Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from May 04, 2017 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: EUR/USD Exchange Rate USD/SEK Exchange Rate ICE Brent Crude Oil Futures Current values of strike and

Interim Report January – March 2017

· Order intake was MSEK 1,314.0 (1,142.0), which is an overall growth of 15.1% adjusted to 4.7% for acquisitions of MSEK 118.0. The overall year to date currency effect is neutral · Net sales were MSEK 1,244.3 (1,031.5), which is an overall growth of 20.6% adjusted to 9.2% for acquisitions of MSEK 118.2. The overall year to date currency effect is neutral · Operating profit was MSEK 153.4 (85.4), representing a 79.6% increase with an operating margin of 12.3 (8.3)% · Earnings after tax were MSEK 107.9 (61.4), an increase of 75.7% · Earnings per share were SEK 2.84 (1.62) · Cash

#17-402 Listing of Turbo warrant issued by BNP Paribas Arbitrage Issuance B.V.

As from May 04, 2017, 1 Turbo warrant issued by BNP Paribas Arbitrage Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Sweden AB. Issuer: BNP Paribas Arbitrage Issuance B.V. Type of security: Call Turbo warrant of European type Execution: Automatic cash settlement Term: As from May 04, 2017 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index For more details see attached file. For further information concerning this NDX notice please contact: NDX

Rhenman & Partners continues its strategic expansion

Susanna Urdmark recruited as Portfolio Manager Rhenman & Partners Asset Management is continuing to expand and has now tied another key person to its Healthcare Team. Susanna Urdmark becomes a new Portfolio Manager for the Healthcare fund Rhenman Healthcare Equity L/S, together with Henrik Rhenman.Susanna Urdmark has extensive experience from both the stock market and the life science sector. Most recently, she was at the Stockholm-based pharmaceutical company Bluefish Pharmaceuticals, where she has been a CFO and a senior management member since 2007. Prior to that, she worked as

There are no items matching the current filter
There are no more items matching the current filter
Back to top